AI is Steroids for Experts: Are You Using it to Scale or Just Stagnate?

In 2026, the biggest threat to small businesses isn't falling behind on AI—it's adopting it without a clear problem to solve. Chris Dore, CEO of Scarlet Nova and founder of Rogue Ventures, warns that AI doesn't replace expertise; it amplifies it, acting like 'steroids for experts.' Companies that rush to implement tools without aligning them to real business needs, delegating AI to isolated departments, or underestimating human judgment are setting themselves up for failure. The real challenge isn't technology—it's change management. Successful adoption starts small, focuses on high-impact pilots, and requires training, clear communication, and leadership that empowers teams rather than overwhelms them. Dore also highlights a growing mental health crisis among founders, calling entrepreneurial success inseparable from psychological resilience. He urges entrepreneurs to protect their internal bandwidth, normalize mental health conversations, and lead from a place of sustainability. Looking ahead, he predicts middle-sized Canadian companies—caught between legacy systems and agile startups—will face the greatest disruption, while those with an AI-first mindset will thrive. His final advice? Just do it—but do it with research, customer focus, and a go-to-market strategy that matters more than ever. The episode underscores a critical truth: AI is not a magic bullet. It’s a mirror. It reveals the strengths and weaknesses of your team, strategy, and leadership.